Recent Finacing
Recent Raise
Cytune Pharma, a Nantes biotech, develops RLI15, an engineered IL-15 immunocytokine that activates cytotoxic T, helper T and NK cells while sparing regulatory T cells, advancing to Phase I.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor